Skip to main content

Table 1 Clinical characteristics of the patients included in this study

From: Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer

Patient #

Sex

Age (years)

cTNM

UICC Stage

GTV Volume (total (primary)) [cc]

1

M

66

T2N3M0

IIIb

95.2 (78.6)

2

F

46

T2N2M0

IIIa

191.1 (169.5)

3

M

65

T3N2M0

IIIa

190.1 (148.8)

4

M

64

T4N2M0

IIIb

230.2 (214.3)

5

F

65

T2N2M0

IIIa

86 (32.8)

6

M

66

T3N2M0

IIIa

107.4 (95.3)

7

M

60

T4N1M0

IIIb

862.4 (853.6)

8

M

71

T2N3M0

IIIb

97.3 (42.8)

9

M

77

T3N2M0

IIIa

304.9 (296.3)

10

M

82

T3N0M0

IIb

63.3 (63.3)